Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Revvity (UK) Limited | 03763278 | £1,677,290 | - |
Government spending data: This supplier has received £244,996,091 in 332 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, NHS England, Manchester University NHS Foundation Trust, East Sussex Healthcare NHS Trust and 7 more public bodies (2016-04-01 to 2026-05-20). View full payment history →